MoleSafe USA Opens Second Location in Albuquerque, New Mexico

Albuquerque the First of Five New Markets Slated to Feature MoleSafe Skin
Cancer Detection Facilities in 2009

ALBUQUERQUE, N.M., April 6 /PRNewswire/ -- MoleSafe (www.molesafe.com), a
company that offers an advanced skin cancer detection program, announced today
it has opened its second U.S. location in Albuquerque, New Mexico. The company
opened its first U.S. location in Millburn, New Jersey, in 2008. MoleSafe
originated in New Zealand, which is the melanoma capital of the world. The
company is scheduled to open in five new markets in the coming year. The
Albuquerque location is overseen by Donald Harville, MD, a Board-certified
dermatologist.

"As skin cancer continues to become increasingly pervasive in the U.S., taking
thousands of lives each year, it is imperative that Americans take
precaution," said Dr. Richard Bezozo, president of MoleSafe USA. "MoleSafe
provides the most advanced and thorough skin cancer detection programs in the
world. We're excited to open our second location in Albuquerque, while
expanding our services to reach more cities and help save more lives."

"MoleSafe's advanced program is a proven answer to skin cancer detection,
specifically melanoma, which is the deadliest of all skin cancers," said Dr.
Donald Harville, manager of the Albuquerque MoleSafe. "When I learned about
MoleSafe's technology and system, I was anxious to help bring it to
Albuquerque. New Mexico ranks as one of the sunniest states in the country,
and thus has one of the highest rates of sun-induced skin cancer."

MoleSafe's four-pronged detection program is utilized by more than 40 melanoma
screening centers around the world. To date, MoleSafe has archived more than
one million lesions, and close to two and half million lesion images, into its
central database. These images have been made available to Memorial
Sloan-Kettering Cancer Center and other top institutions in the U.S. for
melanoma research and study. Additionally, clinical studies have shown that
the number of melanoma cases detected by the MoleMap technology could be up to
15 times greater than those detected via conventional techniques.

The MoleSafe procedure represents a new standard of care and is part of a
life-long program for the early detection of melanoma. It has four key
elements:
-- Risk assessment: Using its database, MoleSafe has developed a risk
assessment model that can help identify patients who may be at higher
risk of melanoma;
-- Serial Digital Dermoscopy: Individual moles are imaged
microscopically,
and tagged to their location on the body for subsequent diagnosis,
identification and comparison over time;
-- Diagnosis and Management: The patient's complete skin record,
including digital images and clinical information, is sent via a
secure
tele-dermatology network to MoleSafe's international panel of
world-class melanoma dermatologists (dermoscopists) for analysis and
reporting. Patients and their designated doctors receive their reports
and their digital melanogram. MoleSafe should be considered an
integral
part of a complete surveillance program for the at-risk melanoma
patient.
-- Education and Follow-up: The MoleSafe melanographer, a trained nurse,
nurse practitioner or physician assistant educates patients about the
risks of sun exposure, and helps generate a continuing partnership
between MoleSafe, the patient and his/her doctor.

The MoleSafe Albuquerque location will implement the licensed skin cancer
detection program and will be managed by Dr. Donald Harville. Dr. Harville
holds his M.D. Degree from the University of Texas Southwestern Medical School
and his M.S. Degree in Dermatology from the University of Minnesota.

About MoleSafe
MoleSafe (www.molesafe.com) is a state-of-the-art procedure involving the
digital imaging, archiving and diagnosis of moles and other suspicious
lesions. The procedure utilizes a combination of high resolution dermoscopy
imaging technology that uses high intensity light to penetrate through the
surface of the skin to show the structure of moles (and other lesions) and a
dermatologist's expert evaluation of the images. In addition to the increased
diagnostic accuracy associated with dermoscopy, MoleSafe is able to detect at
an earlier stage any new, changing and/or suspicious lesions by monitoring and
comparing the images over time. While MoleSafe has the ability to identify all
skin cancers, its primary focus is on the early detection of melanoma.

SOURCE MoleSafe

Stefanie Avery, MWW Group, +1-201-231-6038, savery@mww.com